Delivery Order SPE2DE24DA017-SPE2D625F8C2Z
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $8,250 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 7, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $6,718.99 on June 12, 2025, for the Arthrex ACP Double Syringe System. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of June 17, 2025. This award was issued without a set-aside designation, demonstrating Arthrex's competitive position in the federal healthcare marketplace. The...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order from the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price delivery order, valued at $3,300, is scheduled for completion by September 9, 2025, and represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at...
- Arthrex Inc., a Naples, Florida-based orthopedic medical technology company, received a $4,950 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the Arthrex ACP Double Syringe System. The contract, classified as a non-set-aside delivery order with an ultimate completion date of August 22, 2025, represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $4,356.00 for the Arthrex ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment is scheduled for completion by June 24, 2025, and represents a specific task order issued under Arthrex's larger indefinite delivery contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $5,775 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of July 28, 2025, represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million...
- Arthrex Inc., a leading global orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a $8,664.00 fixed-price delivery order for the ARTHREX ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025. The delivery order, which carries an ultimate completion date of July 28, 2025, represents a task order against Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) valued at $471,048,172.66 and running through...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $1,650 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of September 8, 2025, represents a task order issued under Arthrex's significant Indefinite Delivery Contract (IDC SPE2DE24D0020) valued at $471.0 million and spanning from June...
- Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies, received a $3,300 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the Arthrex ACP Double Syringe System. The contract, which carries an ultimate completion date of September 3, 2025, represents a task order issued against Arthrex's substantial indefinite delivery contract with the Defense Logistics Agency valued at approximately $471...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F8C2ZDelivery Order
Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,475.00 on May 16, 2025, for the ARTHREX ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by May 21, 2025. The award carries no set-aside designation, reflecting Arthrex's strong competitive standing in the federal marketplace. The Medical Supply Chain, operating under the Department of Defense, serves as the funding federal agency. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and extending through September 1, 2029. This comprehensive IDC enables Veterans Affairs medical centers and military healthcare facilities nationwide to procure Arthrex's orthopedic surgical products and biologics. The ACP Double Syringe System being delivered under this order represents one of Arthrex's specialized medical devices designed to support advanced orthopedic surgical procedures for government healthcare systems serving veterans and military personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 5/16/25 |